Blueprint Medicines shares owned by Smith Asset Management Group
Quarter-by-quarter ownership of Blueprint Medicines (BPMC) shares owned by Smith Asset Management Group
from 13F filings
Historical chart of Smith Asset Management Group investment in Blueprint Medicines
Tip: Access up to 7 years of quarterly data
All positions including Blueprint Medicines held by Smith Asset Management Group consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Blueprint Medicines by Smith Asset Management Group
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2021-06-30 | $6.0k | 70 | 85.71 |
| 2021-03-31 | $7.0k | 70 | 100.00 |
| 2020-12-31 | $209k | 1.9k | 112.37 |
| 2020-09-30 | $172k | 1.9k | 92.47 |
| 2020-06-30 | $145k | 1.9k | 77.96 |
| 2020-03-31 | $111k | 1.9k | 58.73 |
| 2019-12-31 | $151k | 1.9k | 79.89 |
| 2019-09-30 | $139k | 1.9k | 73.54 |
| 2019-06-30 | $118k | 1.3k | 94.40 |
| 2019-03-31 | $100k | 1.3k | 80.00 |
| 2018-12-31 | $251k | 4.7k | 53.98 |
| 2018-09-30 | $371k | 4.8k | 78.11 |
| 2018-06-30 | $295k | 4.7k | 63.44 |
| 2018-03-31 | $417k | 4.6k | 91.65 |
| 2017-12-31 | $622k | 8.3k | 75.39 |
| 2017-09-30 | $575k | 8.3k | 69.70 |
More positions owned by Smith Asset Management Group
View all positions for Smith Asset Management Group